Arterial stiffness and microvascular disease in type 2 diabetesAlexios S. Antonopoulos, Dimitris Tousoulis, Gerasimos Siasos et al.|European Journal of Clinical Investigation|2020Cited by 26
ANTHRACYCLINE-INDUCED CARDIO-AND VASO-TOXICITY IN PATIENTS RECEIVING CHEMOTHERAPY FOR BREAST CANCEREvangelos Oikonomou, Dimitris Tousoulis, Flora Zagouri et al.|Journal of the American College of Cardiology|2018Cited by 1
TREATMENT OPTIMIZATION WITH SODIUM/GLUCOSE COTRANSPORTER-2 INHIBITORS, DIPEPTIDYL PEPTIDASE-4 INHIBITORS OR GLYCAGONE LIKE PEPTIDE-1 IMPROVES VASCULAR DYSFUNCTION AND ACHIEVES BETTER GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUSGerasimos Siasos, Dimitris Tousoulis, Evanthia Bletsa et al.|Journal of the American College of Cardiology|2019Cited by 0
Platelet reactivity in patients with type 2 diabetes mellitus after treatment intensification with DPP-4i, SGLT-2i and GLP-1RAGerasimos Siasos, Dimitrios Tousoulis, Stavroula Α. Paschou et al.|Endocrine Abstracts|2019Cited by 0
3-OR: Differential Effects of Novel Antidiabetic Agents on Vascular Function Indices in Patients with Type 2 Diabetes MellitusGerasimos Siasos, N. Tentolouris, Evanthia Bletsa et al.|Diabetes|2019Cited by 0